The Claim

Liraglutide administration results in an 8% reduction in body weight among non-diabetic individuals.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
92score
Challenges
44score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Cause and effect
3 studies reviewed
In plain English

Liraglutide causes an 8% loss of body weight in people who do not have diabetes.

See the scientific wording

Liraglutide leads to 8% body weight loss in non-diabetic patients.

What the research says

3 studies

  1. Study: Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults

    This study shows that people without diabetes who took liraglutide lost about 17 pounds (7.8 kg) in a year, which is roughly 8% of their body weight, supporting the claim.

  2. Study: Differential impact of glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss in the type 2 diabetic and non-diabetic populations.

    The study shows that people without diabetes who take liraglutide or similar drugs lose about 15.7% of their body weight in a year, which is even more than the 8% claimed, so the claim is supported.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 3 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.